What question did this study set out to answer?

This research aims to investigate interactions between bone marrow mesenchymal stem cells and leukemic cells and explore conditioned media as a treatment for leukemia.

February 25, 2026Cancer Immunology Immunotherapy0 citationsOpen Access

Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent

MNManasi NagareHomi Bhabha National Institute MSMonalisa SahooAdvanced Centre for Treatment, Research and Education in Cancer MSManju SengarHomi Bhabha National Institute

Key Points

This research aims to investigate interactions between bone marrow mesenchymal stem cells and leukemic cells and explore conditioned media as a treatment for leukemia.
Analyzed interactions between leukemic cells and MSC in the bone marrow microenvironment.
Evaluated the effects of MSC-conditioned media on leukemia cell growth.
Assessed chemosensitivity enhancement with MSC-CM.
MSC-conditioned media significantly decreases leukemia tumor growth.
MSC-CM enhances the effectiveness of chemotherapy treatments.
MSC-CM holds potential as an immunomodulatory therapeutic agent for leukemia.

Abstract

Summarizing, the leukemic blasts and AML-MSC in the BM microenvironment interact differentially in cell-cell contact compared to only soluble factors. Further, our study has provided innovative leads that PD-MSC-CM effectively abrogates leukemia tumor growth, enhances chemosensitivity and can be developed further as an immunomodulatory novel "off-the-shelf" therapeutic agent for leukemia.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper